| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.3 | 0.08 |